This compound is a pharmaceutical intermediate used in the synthesis of statins. It contains a complex aromatic and heterocyclic structure with multiple functional groups, consistent with its role as a building block in the manufacture of cholesterol-lowering medications.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 93957-52-9
Fluvastatin methyl ester
pharmaceutical intermediate for statin synthesis
(R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
Pharmaceutical intermediate for statin synthesis
3-Pyridin-3-yl-D-alanine--hydrogen chloride (1/2)
pharmaceutical intermediate
3-BROMO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Pharmaceutical intermediate
Ethyl 4-(butylamino)benzoate
Pharmaceutical intermediate
5-Chlorobenzotriazole
peptide coupling reagent intermediate
1,1-Dimethylethyl (6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-5-hydroxy-3-oxo-6-heptenoate
statin HMG-CoA reductase inhibitor
FLUVASTATIN SODIUM
active pharmaceutical ingredient
methyl (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3-hydroxy-5-oxohept-6-enoate
KYRVMHRSMHMKAP-OUKQBFOZSA-N
CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(=O)CC(CC(=O)OC)O)C3=CC=C(C=C3)F